Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-024063
Filing Date
2016-07-01
Accepted
2016-07-01 16:30:22
Documents
1
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4026
  Complete submission text file 0000899243-16-024063.txt   5486
Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
THOMAS FRANK E (Reporting) CIK: 0001242616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36510 | Film No.: 161747296

Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Issuer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations